Search
(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene
go.drugbank.com/drugs/DB08264ExperimentalThis compound belongs to the naphthalenes. These are compounds containing a naphthalene moiety, which consists of two fused benzene rings.
ECT-001 expanded cord blood
go.drugbank.com/drugs/DB21745Investigational[L52013] It is being investigated in hematopoietic cell transplantation as ECT-001 expanded cord blood can demonstrate enhanced stem cell proliferation and engraftment compared to untreated UBCs. … ECT-001 expanded cord blood is umbilical cord blood (UCB) that has been co-cultured and expanded with the small molecule agonist [UM-171].
Ezurpimtrostat
go.drugbank.com/drugs/DB16458InvestigationalCategories: Experimental Unapproved Treatments for COVID-19LSALT Peptide
go.drugbank.com/drugs/DB16472InvestigationalCategories: Experimental Unapproved Treatments for COVID-19Porfiromycin
go.drugbank.com/drugs/DB06478InvestigationalIt belongs to the family of drugs called anticancer antibiotics.
Cytochrome P450 1A Subfamily
go.drugbank.com/bio_entities/BE0010229TargetHumansCatalyzes two successive oxidative transformation of all-trans retinol to all-trans retinal and then to the active form all-trans retinoic acid (PubMed:10681376). … Catalyzes two successive oxidative transformation of all-trans retinol to all-trans retinal and then to the active form all-trans retinoic acid (PubMed:10681376).
Synonyms: Cytochrome P450 form 6Pyrrolnitrin
go.drugbank.com/drugs/DB13603ExperimentalCategories: Antifungals for Topical Use, Antifungals for Dermatological UseBenzylfentanyl
go.drugbank.com/drugs/DB09182ExperimentalIllicitBenzylfentanyl (R-4129) is a fentanyl analog opioid that was on the list of Schedule I drugs in America in 1985 due to its structural similarity to fentanyl. … In 2010 it was removed from the list after it was found to have minimal opioid activity.
XL820
go.drugbank.com/drugs/DB05146InvestigationalXL820 is investigated for use/treatment in solid tumors. XL820 is a solid.
9-(4-hydroxybutyl)-N2-phenylguanine
go.drugbank.com/drugs/DB02495ExperimentalThis compound belongs to the hypoxanthines. These are compounds containing the purine derivative 1H-purin-6(9H)-one. 9-(4-hydroxybutyl)-n2-phenylguanine is known to target thymidine kinase.